signalgroup

Get more out of your business.

Reach it with Microsoft Dynamics 365 Business Central.

August 7, 2023 signalgroup

Biosimilars Forum Scientific Publication Identifies Pathway to Streamlined Development for Biosimilars

July 25, 2023 signalgroup

Biosimilars Forum Applauds Boehringer Ingelheim for Launch of Cyltezo®

July 10, 2023 signalgroup

Biosimilars Forum Congratulates Fresenius Kabi for Launch of IDACIO®

July 6, 2023 signalgroup

Biosimilars Forum Applauds Sandoz for Launch of Hyrimoz®

July 6, 2023 signalgroup

Biosimilars Forum Applauds Organon and Samsung Bioepis for Launch of HADLIMA™

July 5, 2023 signalgroup

Biosimilars Forum Applauds Coherus for Launch of YUSIMRY™

June 30, 2023 signalgroup

Delivering on a Watershed Moment for Biosimilars and Patients

April 10, 2023 signalgroup

Biosimilars Key to Lowering Healthcare and Prescription Drug Costs, According to Employers

March 30, 2023 signalgroup

Biosimilars Forum Applauds the U.S. Senate Finance Committee for Holding PBMs Accountable for Prioritizing Profits over Patients

March 3, 2023 signalgroup

Biosimilars Forum Applauds Congressman Hudson for Supporting Biosimilars Through Shared Savings Legislation